{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:31:17Z","timestamp":1761895877267},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T00:00:00Z","timestamp":1400284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00520-014-2248-6","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T10:34:57Z","timestamp":1400236497000},"page":"2911-2916","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Aprepitant for the control of delayed nausea and vomiting associated with the use of high-dose melphalan for autologous peripheral blood stem cell transplants in patients with multiple myeloma: a phase II study"],"prefix":"10.1007","volume":"22","author":[{"given":"Thomas","family":"Bechtel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"McBride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Bullington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig C.","family":"Hofmeister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Don M.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Jaglowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Penza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie A.","family":"Andritsos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Devine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,17]]},"reference":[{"issue":"suppl 4","key":"2248_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.seminoncol.2004.02.015","volume":"31","author":"J Kaufman","year":"2004","unstructured":"Kaufman J, Lonial S (2004) Multiple myeloma: the role of transplant and novel treatment strategies. Semin Oncol 31(suppl 4):99\u2013105","journal-title":"Semin Oncol"},{"key":"2248_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","volume":"54","author":"A Jemal","year":"2004","unstructured":"Jemal A, Tiwari RC, Murray T et al (2004) Cancer statistics: 2004. Ca Cancer J Clin 54:8\u201329","journal-title":"Ca Cancer J Clin"},{"key":"2248_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(04)15736-X","volume":"363","author":"B Sirohi","year":"2004","unstructured":"Sirohi B, Powles R (2004) Multiple myeloma. Lancet 363:875\u2013887","journal-title":"Lancet"},{"key":"2248_CR4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/107327480401100218","volume":"11","author":"C Gasparaetto","year":"2004","unstructured":"Gasparaetto C (2004) Stem cell transplantation for multiple myeloma. Cancer Control 11:119\u2013129","journal-title":"Cancer Control"},{"key":"2248_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JCO.1997.15.1.103","volume":"15","author":"PJ Hesketh","year":"1997","unstructured":"Hesketh PJ, Kris MG, Grunberg SM et al (1997) JCO 15:103\u2013109","journal-title":"JCO"},{"key":"2248_CR6","first-page":"84","volume":"91","author":"J Lopez-Jimenez","year":"2006","unstructured":"Lopez-Jimenez J, Martin-Ballestros E, Sureda A et al (2006) Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: results of a multicenter, observational study. Haematologica 91:84\u201391","journal-title":"Haematologica"},{"key":"2248_CR7","first-page":"1279","volume":"25","author":"B Abbott","year":"2000","unstructured":"Abbott B, Ippoliti C, Hecth D et al (2000) BMT 25:1279\u20131283","journal-title":"BMT"},{"key":"2248_CR8","doi-asserted-by":"publisher","first-page":"834","DOI":"10.7326\/0003-4819-113-11-834","volume":"113","author":"PH DeMulder","year":"1990","unstructured":"DeMulder PH, Seynaeve C, Vermorken JB et al (1990) Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study. Ann Intern Med 113:834\u2013840","journal-title":"Ann Intern Med"},{"key":"2248_CR9","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.2165\/11203680-000000000-00000","volume":"69","author":"MP Curran","year":"2009","unstructured":"Curran MP, Robinson DM (2009) Aprepitant: a review of its use in the prevention of nausea and vomiting. Drugs 69:1853\u20131878","journal-title":"Drugs"},{"key":"2248_CR10","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1200\/JCO.2003.01.095","volume":"21","author":"PJ Hesketh","year":"2003","unstructured":"Hesketh PJ, Grunberg SM, Gralla RJ et al (2003) The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin\u2014the Aprepitant Protocol 052 Study Group. J Clin Oncol 21:4112\u20134119","journal-title":"J Clin Oncol"},{"key":"2248_CR11","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1200\/JCO.2005.09.050","volume":"23","author":"DG Warr","year":"2005","unstructured":"Warr DG, Hesketh PJ, Gralla RJ et al (2005) Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy. J Clin Oncol 23:2822\u20132830","journal-title":"J Clin Oncol"},{"key":"2248_CR12","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/annonc\/mdl019","volume":"17","author":"HJ Schmoll","year":"2006","unstructured":"Schmoll HJ, Aapro MS, Poli-Bigelli S et al (2006) Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment. Ann Oncol 17:1000\u20136","journal-title":"Ann Oncol"},{"key":"2248_CR13","unstructured":"Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS. 2003. National Cancer Institute. 16 Dec. 2004. http:\/\/ctep.cancer.gov\/forms\/CTCAEv3.pdf"},{"key":"2248_CR14","first-page":"S14","volume":"19","author":"JM Bliss","year":"1992","unstructured":"Bliss JM, Robertson B, Selby PJ (1992) The impact of nausea and vomiting upon quality of life measures. Br J Cancer Suppl 19:S14\u2013S22","journal-title":"Br J Cancer Suppl"},{"key":"2248_CR15","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/sj.bmt.1703280","volume":"28","author":"KK Ballen","year":"2001","unstructured":"Ballen KK, Hesketh AM, Heyes C et al (2001) Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell support. Bone Marrow Transplant 28:1061\u20131066","journal-title":"Bone Marrow Transplant"},{"key":"2248_CR16","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","volume":"29","author":"E Basch","year":"2011","unstructured":"Basch E, Prestrud AA, Hesketh PJ et al (2011) Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 29:4189\u20134198","journal-title":"J Clin Oncol"},{"key":"2248_CR17","doi-asserted-by":"crossref","unstructured":"Paul B, Trovato JA, Thompson J, Badros AZ, Goloubeva O (2010) Efficacy of aprepitant in patients receiving high-dose chemotherapy with hematopoietic stem cell support. J Oncol Pharm Pract 16(1):45\u201351","DOI":"10.1177\/1078155209105399"},{"key":"2248_CR18","unstructured":"Szer J, Grigg AP, Roberts AW et al (2006) Aprepitant in the prevention of acute and delayed nausea and vomiting following haemopoietic stem cell transplantation: a pilot study. 32nd Annual Meeting of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 37(Suppl 1)"},{"key":"2248_CR19","doi-asserted-by":"crossref","unstructured":"Barnett CM, Oholendt MS, Popat U et al (2004) Evaluation of aprepitant for treatment of acute and delayed chemotherapy-induced nausea and vomiting in patients undergoing autologous stem cell transplantation. Blood 104: 343b (abstract no. 5041)","DOI":"10.1182\/blood.V104.11.5041.5041"},{"key":"2248_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbmt.2012.07.019","volume":"19","author":"PJ Stiff","year":"2013","unstructured":"Stiff PJ, Fox-Geiman MP, Kiley K et al (2013) Prevention of nausea and vomiting associated with stem cell transplant: results of a prospective, randomized trial of aprepitant used with highly emetogenic preparative regimens. Biol Blood Marrow Transplant 19:49\u201355","journal-title":"Biol Blood Marrow Transplant."},{"key":"2248_CR21","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1124\/dmd.104.000216","volume":"32","author":"RI Sanchez","year":"2004","unstructured":"Sanchez RI, Wang RW, Newton DJ et al (2004) Cytochrome P450 3A4 is the major enzyme involved in the metabolism of the substance P receptor antagonist aprepitant. Drug Metab Dispos 32:1287\u201392","journal-title":"Drug Metab Dispos"},{"key":"2248_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00280-005-1005-4","volume":"56","author":"ME Jonge de","year":"2005","unstructured":"de Jonge ME, Huitema AD, Holtkamp MJ et al (2005) Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism. Cancer Chemother Pharmacol 56:370\u20138","journal-title":"Cancer Chemother Pharmacol"},{"key":"2248_CR23","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1365-2125.2010.03792.x","volume":"70","author":"G Egerer","year":"2010","unstructured":"Egerer G, Eisenlohr K, Gronkowski M et al (2010) The NK1 receptor antagonist aprepitant does not alter the pharmacokinetics of high-dose melphalan chemotherapy in patients with multiple myeloma. Br J Clin Pharmacol 70:903\u20137","journal-title":"Br J Clin Pharmacol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2248-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-014-2248-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2248-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2248-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T14:07:07Z","timestamp":1597846027000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-014-2248-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,17]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["2248"],"URL":"https:\/\/doi.org\/10.1007\/s00520-014-2248-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,17]]},"assertion":[{"value":"1 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}